Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc. [electronic resource] by
- Boffa, L C
- Cutrona, G
- Cilli, M
- Matis, S
- Damonte, G
- Mariani, M R
- Millo, E
- Moroni, M
- Roncella, S
- Fedeli, F
- Ferrarini, M
Producer: 20070320
In:
Cancer gene therapy vol. 14
Availability: No items available.
|
|
11.
|
Lack of mutagenicity and clastogenicity of PNAEmu-NLS targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma. [electronic resource] by
- Boffa, L C
- Menichini, P
- Bolognesi, C
- Cutrona, G
- Roncella, S
- Damonte, G L
- Millo, E
- Mariani, M R
- Matis, S
- Russo, D
- Ciliutti, P
- Ferrarini, M
Producer: 20070514
In:
Mutation research vol. 628
Availability: No items available.
|
|
12.
|
PNAEmu can significantly reduce Burkitt's lymphoma tumor burden in a SCID mice model: cells dissemination similar to the human disease. [electronic resource] by
- Matis, S
- Mariani, M R
- Cutrona, G
- Cilli, M
- Piccardi, F
- Daga, A
- Damonte, G
- Millo, E
- Moroni, M
- Roncella, S
- Fedeli, F
- Boffa, L C
- Ferrarini, M
Producer: 20100126
In:
Cancer gene therapy vol. 16
Availability: No items available.
|